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Abstract
 
Although the Src homology 2 domain–containing 5
 
9
 
 inositol phosphatase (SHIP) is a well-
known mediator of inhibitory signals after B cell antigen receptor (BCR) coaggregation with
the low affinity Fc receptor, it is not known whether SHIP functions to inhibit signals after
stimulation through the BCR alone. Here, we show using gene-ablated mice that SHIP is a
crucial regulator of BCR-mediated signaling, B cell activation, and B cell development. We
demonstrate a critical role for SHIP in termination of phosphatidylinositol 3,4,5-triphosphate
(PI[3,4,5]P
 
3
 
) signals that follow BCR aggregation. Consistent with enhanced PI(3,4,5)P
 
3
 
 sig-
naling, we find that splenic B cells from SHIP-deficient mice display enhanced sensitivity to
BCR-mediated induction of the activation markers CD86 and CD69. We further demonstrate
that SHIP regulates the rate of B cell development in the bone marrow and spleen, as B cell
precursors from SHIP-deficient mice progress more rapidly through the immature and transi-
tional developmental stages. Finally, we observe that SHIP-deficient B cells have increased re-
sistance to BCR-mediated cell death. These results demonstrate a central role for SHIP in reg-
ulation of BCR signaling and B cell biology, from signal driven development in the bone
marrow and spleen, to activation and death in the periphery.
Key words: signal transduction • phosphatidylinositol 3-kinase • antigen • BCR • 
phosphatidylinositol 3,4,5-triphosphate
 
Introduction
 
The B cell antigen receptor (BCR)
 
1
 
 plays a central role in B
cell biology, transducing signals that determine cell fate (1).
BCR-mediated signals are required not only for initiation
and regulation of the immune response, but also for B cell
development and survival. Interestingly, a growing body of
evidence indicates that the B cell continuously receives sig-
nals through the BCR, apparently independent of antigen
binding (2). Evidence for the existence and importance of
these signals comes from findings that genetic ablation of
components of the BCR complex (3, 4), or certain BCR
signal transduction intermediaries (5–11), results in devel-
opmental arrest and lack of mature B cells in the periphery.
Furthermore, induced genetic ablation of the BCR, using
conditional knockout mice, results in rapid depletion of the
mature B cell pool (2). Thus, it seems likely that develop-
mental progression and survival in both the bone marrow
and the periphery require constitutive or “tonic” signaling
through the BCR. These data support a hypothesis
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Abbreviations used in this paper:
 
 7AAD, 7-amino-actinomycin D; BCR,
 
B cell antigen receptor; Btk, Bruton’s tyrosine kinase; [Ca
 
2
 
1
 
], intracellular
free calcium; HSA, heat-stable antigen; IP
 
3
 
, inositol 1,4,5-triphosphate;
MAP, mitogen-activated protein; mIg, membrane-bound Ig; NF, nuclear
factor; PI3-K, phosphatidylinositol 3-kinase; PI(3,4)P
 
2
 
, phosphatidylino-
 
sitol 3,4-biphosphate; PI(3,4,5)P
 
3
 
, phosphatidylinositol 3,4,5-triphosphate;
PLC, phospholipase C; SHIP, Src homology 2 domain–containing 5
 
9
 
inositol phosphatase; sIg, surface Ig. 
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wherein both antigen-independent and -dependent signals
emanating from the BCR provide critical stimuli for the se-
lection, development, activation, and survival of B cells.
Transduction of signals through the BCR occurs via
multiple parallel, yet cross-regulating, biochemical path-
ways. Aggregation of the BCR triggers a rapid increase in
tyrosyl phosphorylation of the Ig
 
a/b
 
 signaling components
of the receptor, Src- and Syk-family kinases, and many
downstream effector proteins (12, 13). One of the most
rapidly phosphorylated substrates is CD19, which functions
to recruit and activate phosphatidylinositol 3-kinase (PI3-K)
(14). PI3-K generates phosphatidylinositol 3,4,5-triphos-
phate (PI[3,4,5]P
 
3
 
), which activates a wide range of signaling
molecules through recruitment to the plasma membrane.
PI(3,4,5)P
 
3
 
-mediated activation of the enzymes Bruton’s
tyrosine kinase (Btk) and phospholipase C (PLC)
 
g
 
 results
in generation of inositol polyphosphates (inositol 1,4,5-
triphosphate [IP
 
3
 
]) leading to intracellular calcium release
and extracellular calcium influx (15–19). PI(3,4,5)P
 
3
 
 also
regulates activation of additional signaling pathways includ-
ing those involving Akt (20–22) and mitogen-activated
protein (MAP) kinases (23), and regulates activation of
transcription factors including nuclear factor (NF)-
 
k
 
B (24–26).
Furthermore, loss of PI(3,4,5)P
 
3
 
 generation, through ge-
netic ablation of the regulatory subunit of PI3-K, p85
 
a
 
,
 
 
 
re-
sults in an absence of mature B cells in the periphery (9,
10). Thus, signaling cascades that mediate production of
PI(3,4,5)P
 
3
 
 are critical not only for active BCR-mediated
responses, but also for B cell development and survival.
PI(3,4,5)P
 
3
 
 signals are attenuated upon BCR coaggrega-
tion with the low affinity Fc receptor, Fc
 
g
 
RIIB1 (27–29).
This inhibition occurs via recruitment of the Src homology
2 domain–containing 5
 
9
 
 inositol phosphatase (SHIP),
which hydrolyzes the 5
 
9
 
 phosphate from PI(3,4,5)P
 
3
 
 to
produce phosphatidylinositol 3,4-biphosphate (PI[3,4]P
 
2
 
)
(30–32). This hydrolysis disrupts BCR-mediated activation
of Btk and PLC
 
g
 
, and consequently, the calcium mobiliza-
tion response (32, 33). In both the chicken DT40 B cell
lymphoma line and in ex vivo B cells, genetic ablation of
SHIP abrogates Fc
 
g
 
RIIB1-mediated inhibition of the bio-
chemical processes described above (17, 21, 34).
Although these results establish SHIP as a crucial nega-
tive regulator of B cell signaling during BCR–Fc
 
g
 
RIIB1
coaggregation, the role of SHIP during autonomous BCR
signaling is not defined. However, recent data have dem-
onstrated increased calcium mobilization and Akt activa-
tion upon aggregation of the BCR in SHIP-deficient
DT40 cells (21, 35). Also important in this regard is the fact
that BCR aggregation leads to tyrosine phosphorylation of
SHIP and its association with linker molecules including
Shc (36), suggesting a possible role for SHIP in regulation
of BCR signaling. Recently, it has been reported that mice
deficient in SHIP display elevated levels of serum antibody,
splenomegaly, and increased mortality (34, 37).
To define the role of SHIP in BCR-mediated signal
transduction and in B cell biology, we examined ex vivo B
cells from SHIP-deficient mice. We found that BCR li-
gation in SHIP-deficient B cells resulted in levels of
 
PI(3,4,5)P
 
3
 
 that were elevated over fivefold compared with
wild-type littermates. Additionally, we found that SHIP
regulates the biological outcome of signaling through the
BCR. SHIP-deficient B cells were more sensitive to BCR-
mediated induction of the activation markers CD86 and
CD69. Furthermore, SHIP-deficient B cells displayed ac-
celerated temporal development in the bone marrow, sug-
gesting that PI(3,4,5)P
 
3
 
 signals affect the rate of positive se-
lection of immature B cells. SHIP ablation also resulted in
accelerated maturation of transitional B cells in the spleen.
Thus, SHIP normally limits the rate of B cell development
from the immature stage onward through maturation in the
periphery. Finally, we determined that SHIP functions as a
positive regulator of BCR-induced cell death. These results
demonstrate a central role for SHIP in regulation of BCR
signaling and B cell biology, from tonic signal–driven de-
velopment in the bone marrow and spleen, to activation
and death in the periphery.
 
Materials and Methods
 
Reagents and Antibodies.
 
Purified rabbit anti–mouse IgG anti-
body (H
 
1
 
L) F(ab
 
9
 
)
 
2
 
 fragments were purchased from Zymed, and
used for cell stimulation. Antibodies directed against the following
molecules were used for flow cytometry: MHC class II (I-A
 
b/d
 
,
D3.137; clone was provided by S. Tonkonogy, North Carolina State
University, Raleigh, NC), CD21 (7G6; PharMingen), CD23 (B3B4;
PharMingen), CD24 (M1/69; PharMingen), CD45R (anti-B220,
RA3-6B2; PharMingen), CD43 (Ly 48; PharMingen), CD69
(H1.2F3; PharMingen), CD86 (GL-1; PharMingen), IgD (JA12.5),
IgM (polyclonal; Caltag), and mAb 493 (a gift from A. Rolink, Basel
Institute for Immunology, Basel, Switzerland). 7-amino-actino-
mycin D (7AAD; via probe) was purchased from PharMingen, and
propidium iodide and LPS (055:B5) were purchased from Sigma
Chemical Co.
 
Animals and Cells.
 
All animals used in this study were age-
matched 6–10-wk-old SHIP
 
2/2
 
 mice and control SHIP
 
1/1
 
 litter-
mates generated as the F1 progeny of SHIP
 
1/2
 
 mice (37). Usually
mice between 6 and 8 wk old were used to avoid the pathology
associated with aged SHIP
 
2/2
 
 mice (37). Splenic B cells were
prepared as described previously (16). In brief, spleens were ex-
cised from mice, cells were dispersed, and RBCs were lysed using
Gey’s solution. For studies of induction of activation marker ex-
pression and cell survival, splenocytes were depleted of T cells by
complement lysis using HO13.4 and T24 antibodies, and B cells
were further purified by discontinuous Percoll density gradient
centrifugation (
 
r
 
 
 
. 
 
1.07). Purified B cells were cultured with
0–12 
 
m
 
g/ml F(ab
 
9
 
)
 
2
 
 anti-IgG in 20% fetal bovine serum, with
100 IU/ml penicillin and 100 
 
m
 
g/ml streptomycin for 6–24 h.
Bone marrow cells were prepared by flushing femurs with
IMDM to dislodge cells, followed by gentle deaggregation using
a 5-ml syringe. Bone marrow was depleted of RBCs using Gey’s
solution and washed twice in IMDM.
 
Phenotypic Analysis.
 
Cells were washed, resuspended in PBS
containing 1% BSA and 0.1% sodium azide, and incubated with
optimal concentrations of directly conjugated antibody. Cells were
incubated for 30 min at 4
 
8
 
C and washed twice in PBS/BSA/azide.
After washing, cells were analyzed by flow cytometry. Cell viability
was assessed by exclusion of 7AAD or propidium iodide.
 
Calcium Mobilization.
 
For measurements of intracellular free
calcium ([Ca
 
2
 
1
 
]
 
i
 
), 10
 
6
 
 cells/ml in IMDM cells were loaded with 
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Indo-AM (Molecular Probes, Inc.), and stimulated with F(ab
 
9
 
)
 
2
 
anti-IgG antibody. Mean [Ca
 
2
 
1
 
]
 
i
 
 was evaluated over time using a
flow cytometer (model 50H; Ortho Diagnostic Systems, Inc.)
with appended data acquisition system and MultiTime software
(Phoenix Flow Systems) as described previously (16).
 
Measurement of B Cell Survival.
 
Freshly purified splenic B cells
were either left unstimulated, or were stimulated with 1–12 
 
m
 
g/ml
of F(ab
 
9
 
)
 
2
 
 anti-IgG antibody. After 24 h of incubation, cell viabil-
ity was assessed by exclusion of propidium iodide. Experiments
were performed in triplicate wells.
 
Measurement of PI(3,4,5)P
 
3
 
 and PI(3,4)P
 
2
 
 Generation.
 
Splenic B
cells from SHIP
 
2/2
 
 or SHIP
 
1/1
 
 control littermates were depleted
of RBCs and T cells and further purified by discontinuous Percoll
density gradient centrifugation as described above. Cells were cul-
tured for 48 h in 20% fetal bovine serum as described above with
the addition of 25 
 
m
 
g/ml LPS (incorporation of 
 
32
 
P label into the
cellular ATP pool requires actively metabolizing cells). After 48 h
in culture, cells were harvested, washed three times, and incubated
for 90 min at 10
 
7
 
 cells/ml in low phosphate medium with 0.5
mCi/ml 
 
32
 
P-orthophosphate. 
 
32
 
P-labeled cells were stimulated
with F(ab
 
9
 
)
 
2
 
 fragments of anti-IgG for the indicated time, and im-
mediately lysed in 2.4 N HCl/methanol/chloroform (1:0.9:1.4
vol/vol/vol). Lipids were extracted, deacylated with methanol/
25% methylamine/
 
n
 
-butanol, and analyzed by HPLC on a SAX
ion exchange column (Phenomenex) as described previously (38).
 
Measurement of IP
 
3
 
 Generation.
 
IP
 
3
 
 generation was measured
using a 
 
3
 
H radioreceptor inhibition assay kit (DuPont-NEN) ac-
cording to the manufacturer’s instructions. Splenic B cells used in
this study were first cultured for 48 h as described above.
 
Sublethal Irradiation and Autoreconstitution.
 
Age-matched SHIP
 
2/2
 
and SHIP
 
1/1
 
 littermates were treated with 500 rads of whole body
irradiation 0–14 d before killing (39). For studies of autoreconsti-
tution, single cell suspensions of spleen or bone marrow were de-
pleted of RBCs, stained, and analyzed by flow cytometry.
 
Results
 
SHIP
 
2/2
 
 B Cells Display Elevated PI(3,4,5)P
 
3
 
 Levels upon
BCR Aggregation.
 
To define the role of SHIP in modula-
tion of BCR signaling, levels of PI(3,4,5)P
 
3
 
 and its break-
down product, PI(3,4)P
 
2
 
, were measured by HPLC (31, 38)
after stimulation of splenic B cells derived from SHIP
 
2/2
 
mice and normal littermates. Aggregation of the BCR
with F(ab
 
9
 
)
 
2
 
 fragments of anti–mouse Ig resulted in an in-
crease in levels of radiolabeled PI(3,4,5)P
 
3
 
 in both SHIP
 
2/2
 
and SHIP
 
1/1
 
 cells (Fig. 1 A); however, the induced increase
in PI(3,4,5)P
 
3
 
 was significantly greater in B cells from
SHIP
 
2/2 
 
mice. After stimulation of SHIP
 
2/2 
 
B cells,
PI(3,4,5)P
 
3
 
 levels increased at least fivefold at all measured
time points compared with wild-type cells. Particularly
striking was the more sustained nature of the PI(3,4,5)P
 
3
 
signal observed upon BCR aggregation. PI(3,4,5)P
 
3 levels
remained highly elevated in B cells from SHIP2/2 mice
throughout the duration of the experiment. Loss of
PI(3,4,5)P3 after stimulation of wild-type cells was primarily
attributable to degradation by SHIP, as levels of the SHIP
breakdown product, PI(3,4)P2, were significantly elevated
in the control cells compared with SHIP2/2 cells (Fig. 1 B).
These results show that most of the PI(3,4,5)P3 produced
upon BCR ligation is rapidly hydrolyzed by SHIP, causing
a reduction both in the peak levels of PI(3,4,5)P3 and in the
duration of the PI(3,4,5)P3 response. Interestingly, a small
but significant amount of PI(3,4,5)P3 degradation and con-
version to PI(3,4)P2 was observed in SHIP2/2 B cells, sug-
gesting the presence of a second 59 inositol phosphatase.
This may be the recently described SHIP-2 (40). From our
results, it is apparent that degradation of PI(3,4,5)P3 that
follows stimulation through the BCR is primarily mediated
through SHIP, and therefore SHIP plays a significant role in
regulation of BCR signaling pathways that are PI(3,4,5)P3
dependent.
Although the rate of PI(3,4,5)P3 degradation was in-
creased in the SHIP1/1 cells, the additive counts from
PI(3,4)P2 plus PI(3,4,5)P3 (Fig. 1, A plus B) were approxi-
mately equivalent in the two cell populations, suggesting
that PI3-K was equally active. BCR-mediated activation of
PI3-K is primarily dependent on phosphorylation of CD19,
and CD19 phosphorylation was found to be comparable
between the two cell populations (data not shown). In con-
clusion, analysis of phosphatidylinositol levels reveals that
SHIP is a primary regulator of PI(3,4,5)P3 levels. After ag-
gregation of the BCR, SHIP significantly attenuates both
the peak and the duration of the PI(3,4,5)P3 response.
One of the effects of BCR aggregation downstream of
PI(3,4,5)P3 is activation of PLCg and consequent mobiliza-
tion of calcium. To determine whether PI(3,4,5)P3 genera-
tion limits BCR-mediated PLCg activation, the BCR was
aggregated and subsequent IP3 generation and calcium mo-
bilization were measured in SHIP2/2 and SHIP1/1 cells.
Figure 1. SHIP terminates PI(3,4,5)P3 signals generated upon BCR
aggregation. (A and B) B cells from SHIP2/2 or control littermates were
labeled with 32P-orthophosphate for 1.5 h. The cells were then stimulated
with F(ab9)2 fragments of anti-IgG (12 mg/ml) for the indicated time and
immediately lysed with methanol/chloroform. Phospholipids were ex-
tracted, deacylated, and fractionated by HPLC. The fractions containing
PI(3,4,5)P3 (A) and the SHIP breakdown product, PI(3,4)P2 (B), were
quantitated by liquid scintillation. (C) IP3 (Ins 1,4,5 P3) levels in SHIP2/2
and control B cells after stimulation with F(ab9)2 anti-IgG (12 mg/ml). (D)
Intracellular free calcium levels ([Ca21]i) were monitored after F(ab9)2
anti-IgG (10 mg/ml) stimulation of Indo-1–loaded B cells derived from
SHIP2/2 or wild-type littermates.1548 SHIP Inhibits B Cell Signaling, Maturation, and Activation
SHIP2/2  B cells display equivalent IP3 production and
slightly increased calcium mobilization after F(ab9)2 anti-Ig
stimulation (Fig. 1, C and D). These results indicate that
PI(3,4,5)P3 levels achieved during BCR signaling, in either
SHIP2/2 or wild-type B cells, are sufficient to support
PLCg activation. However, other PI(3,4,5)P3-dependent
signaling pathways, and their downstream biologic se-
quelae, may be affected by excessive PI(3,4,5)P3 accumula-
tion in SHIP2/2 B cells.
Reduced Numbers of Immature and/or Transitional B Cells
and Increased Numbers of Mature B Cells in the Periphery of
SHIP-Deficient Mice. The biological consequences of
SHIP modulation of BCR signaling are poorly defined. It
has been reported that mice deficient in SHIP have elevated
levels of serum antibody, splenomegaly, and increased mor-
tality (34, 37). B cells from SHIP2/2 mice are reduced in
number by 50% in the bone marrow, and yet surprisingly,
increased by #50% in the spleen (34, 37). As these observa-
tions imply a role for SHIP in regulation of B cell develop-
ment, we compared splenic B cell development in SHIP2/2
and wild-type mice. The majority of IgMhiIgDlow cells are
transitional (T1) cells (39, 41, 42), which are recent immi-
grants from the bone marrow. These cells require constitu-
tive BCR-derived signals to progress to the IgMhiIgDhi (T2)
stage (42). Additional BCR-mediated signals then allow the
cell to progress to the IgMloIgDhi (M) mature stage (42). In
spleens of SHIP2/2 mice, there is a two- to threefold reduc-
tion in the total number of the most immature (T1) cells, as
well as a 1.5-fold reduction in the T2 population (Fig. 2 A,
and Table I). This conclusion is based on analyses in
which contaminating marginal zone cells, distinguished as
IgMhiIgDlowCD21hi, were excluded from the T1 popula-
tion (Fig. 2 B, and Table I). Curiously, marginal zone cells
are also underrepresented in the spleens of SHIP-deficient
mice. Finally, the mature IgMloIgDhi population of cells ap-
pears to be overrepresented. It is also of interest that surface
Ig (sIg)M levels on mature, SHIP2/2 B cells are reduced by
two- to fivefold compared with control B cells. The reduc-
tion in numbers of transitional B cells in the spleen of
SHIP2/2 mice, as well as the downregulation of sIgM, sug-
gests a role for SHIP in regulation of maturation, possibly
due to overamplification of BCR-generated signals.
To confirm that the unusual splenic B cell phenotype
represents increased numbers of mature and reduced num-
bers of transitional cells, we examined levels of heat-stable
antigen (HSA) and B220 on splenic B cells (39). B cells
from the SHIP2/2 mice showed reduced numbers of HSAhi
cells (Fig. 2 C), which further demonstrates that the B cell
population has a more mature phenotype. Two additional
surface markers expressed on mature cells, CD23 and MHC
class II, were also significantly elevated on SHIP2/2 cells
(data not shown). In conclusion, SHIP deficiency causes
Figure 2. Reduced numbers of immature/transitional, but increased
numbers of mature B cells in the spleens of SHIP2/2 mice. Spleen cells
from 7-wk-old SHIP2/2 and SHIP1/1 littermates were RBC-lysed and
directly stained (A) for B220, IgM, 7AAD (via probe), and IgD. Cells
were analyzed by flow cytometry, and gated for viable/B2201 cells. Early
transitional cells in region T1 (mIgMhimIgDlo) decreased from 16 (con-
trol) to 4% of the B cell population in SHIP deficiency, late transitional B
cells in region T2 are reduced from 20 to 9%, while the percentage of
mature cells in region M (IgMloIgDhi) are increased 1.5-fold by SHIP de-
ficiency. To eliminate marginal zone cells from the presumptive T1 pop-
ulation (T1), gated cells (IgMhiIgDlo/2) were stained for CD21 (B) to de-
termine the population of marginal zone B cells. To further analyze B cell
maturation, cells were stained for B220, and HSA (C). A decrease in the
transitional HSAhi population is apparent in SHIP2/2 B cells.
Table I. Representation of Splenic B Cell Subpopulations from 
SHIP1/1 and SHIP2/2 Mice
SHIP1/1 SHIP2/2
3106 3106
Total (B2201) 37.9 6 3.0 58.1 6 3.5
Mature (IgD1IgM1) 24.2 6 1.9 50.4 6 3.2
T2 (IgD1IgMhi) 7.6 6 0.6 5.2 6 0.4
T1 (IgD2IgMhCD212) 5.3 6 0.5 2.2 6 0.2
MZ (IgD2IgMhiCD21hi) 0.8 6 0.1 0.2 6 0.1
Single cell suspensions were prepared from the spleens of 7-wk-old
mice, labeled with the indicated antibodies, and analyzed by FACS®.
The data are the mean of the number of cells (in millions) 6 SD of three
individual mice analyzed. MZ, marginal zone.1549 Brauweiler et al.
developmental abnormalities in B cells leading to a decrease
in the number of transitional cells and increased numbers of
mature splenic B cells.
Accelerated Development of Transitional B Cells in SHIP-defi-
cient Mice. Data described above suggest that SHIP regu-
lates B cell development. Specifically, levels of PI(3,4,5)P3,
determined by SHIP expression and function, may affect
the rate of B cell maturation. As a consequence, B cells may
traverse development more rapidly in SHIP2/2 mice. To
address this possibility, we used the autoreconstitution sys-
tem described by Cancro and colleagues (39, 41) to analyze
B cell development. In this system, the B cell compartments
of adult mice are depleted by sublethal irradiation, allowing
newly generated bone marrow–derived B cells to repopu-
late the spleen. In normal mice, peripheral lymphoid organs
are devoid of lymphocytes 9 d after irradiation, with signifi-
cant reconstitution appearing at 11–13 d. Virtually all newly
formed B cells detected at this time point bear the transi-
tional phenotype, HSAhi, B220lo, IgMhi, and sIgDlo.
B cell development in irradiated mice was evaluated
based on quantitation of total numbers of B cells in the
spleen, as well as their surface expression of IgM, IgD,
CD24 (HSA), and B220. The kinetics of regeneration of B
cells in the spleen was compared between SHIP2/2 and
control littermates (Fig. 3 A). 5 d after irradiation, .99%
of the B cells were depleted from the spleens of both
SHIP2/2 and SHIP1/1 mice, indicating that B cells in both
mice were radiation sensitive. Although no production of
cells was seen at day 7, by day 10 there were 5–10-fold
more B cells in the spleens of the SHIP2/2 mice than in
wild-type littermates. In SHIP2/2 mice, B cells repopu-
lated the spleen 9–11 d after irradiation, while in wild-
type littermates, reconstitution occurred after 11–13 d.
Through the subsequent period of the experiment, in-
creased numbers of B cells accumulated in the spleens of
SHIP2/2 mice compared with SHIP1/1 mice.
We were interested in determining whether progression
of transitional B cells to the mature stage was also acceler-
ated in irradiated SHIP2/2 mice. Typically, this phenotypic
transition occurs over a 2–4-d period (39). The kinetics of
appearance of the mature phenotype, as determined by de-
creasing expression of membrane-bound Ig (mIg)M and
HSA (Fig. 3 B), revealed changes consistent with acceler-
ated conversion of immature to mature splenic B cells in
the SHIP-deficient mice. By day 12 after irradiation, only
the SHIP-deficient B cells displayed the lower levels of
mIgM and HSA typical of mature B cells. The trend for in-
creased rate of maturation in the SHIP-deficient B cells
continued 14 d after irradiation. Furthermore, significant
numbers of SHIP2/2 B cells rapidly downmodulate mIgM
to very low levels. In summary, deletion of SHIP appar-
ently leads to increased entry of immature B cells into the
spleen and increased rate of maturation of transitional cells
as reflected by downmodulation of IgM and HSA.
SHIP Deficiency Causes Accelerated Development of Imma-
ture Cells in the Bone Marrow. The results presented above
indicate that SHIP deficiency leads to prolonged elevation
of PI(3,4,5)P3 and altered developmental progression from
the transitional to mature stage in B cells, supporting a hy-
pothesis that BCR-derived signals regulate developmental
progression in the periphery. As tonic, or constitutive, sig-
nals also appear to be required for B cell development in
the bone marrow, and because emigration of B cells into
the spleen of SHIP2/2 mice is accelerated, it seemed plausi-
ble that bone marrow development also could be acceler-
ated. To explore this possibility, we examined bone mar-
row populations during autoreconstitution in SHIP2/2 and
SHIP1/1 mice. Although total numbers of B2201 cells in
the bone marrow were similar between the autoreconsti-
tuted B cell populations of SHIP2/2 and control litter-
mates, phenotypic analysis revealed differences in the rates
of development of early B cell subpopulations. To charac-
terize these populations, we used the 493 mAb, which has
been recently reported by Rolink et al. as a marker of early
B cell development (43, 44). This mAb specifically recog-
nizes pro-, pre-, and immature cells of the B cell lineage,
while mature cells are not recognized. Furthermore, its ex-
pression is significantly diminished on normal transitional
Figure 3. B cell development in
SHIP2/2 mice is accelerated. 6–10-
wk-old SHIP2/2 mice and wild-type
littermates were treated with 500
rads of radiation, and the kinetics of
regeneration of B cells in the spleen
was monitored. (A) Time course of
autoreconstitution of B2201 cells in
the spleens of SHIP1/1 and SHIP2/2
mice. (B) 12 and 14 d after sublethal
irradiation, splenocytes from 8-wk-
old SHIP1/1 and SHIP2/2 litter-
mates were harvested and stained for
the maturation markers IgM and
HSA (live/B2201 gate). Data shown
represent the mean of three inde-
pendent experiments.1550 SHIP Inhibits B Cell Signaling, Maturation, and Activation
cells (data not shown, and reference 44). Therefore, pro-
gression to the transitional/mature phenotype can be fol-
lowed by decreased mAb 493 binding, and allows a simple
way to distinguish between immature and mature B cells in
the bone marrow. 493/anti-IgM analysis of normal bone
marrow during autoreconstitution reveals that B cells
progress through the 493hiIgM2 pool (pro/pre), and the
493hiIgM1 (immature) to the 493loIgM1 (transitional)
stages. From the data in Fig. 4 (top), mAb 4931 (pro/pre)
cells appear with similar kinetics in both the SHIP-defi-
cient and wild-type mice. However, 493hiIgM1 (imma-
ture) B cells are increased twofold, and 493loIgM1 (transi-
tional) B cells are increased fourfold in SHIP2/2 mice by
day 9 (Fig. 4, bottom). In the autoreconstitution model,
downmodulation of 493 correlates well with emigration
from the bone marrow to the periphery, as repopulation of
B cells into the spleen also starts to occur at day 9 in the
SHIP-deficient but not the control mice (Fig. 3 A). In
control mice, IgM1493lo (transitional) cells appeared z1–2 d
later. It should be noted that at later time points the per-
centage of IgM1 cells in the bone marrow of SHIP2/2
mice was reduced compared with the SHIP1/1 mice (data
not shown), possibly reflecting the accelerated maturation
and emigration of IgM1 cells to the spleen. In view of pre-
vious studies implicating BCR-mediated signaling in de-
velopment, these results suggest that increased levels of sig-
naling drive accelerated maturation of the SHIP2/2 bone
marrow B cells through the immature, transitional, and
mature stages of development.
SHIP Attenuates BCR-mediated Activation of CD69 and
CD86 Expression. We next assessed the role of SHIP in
modulating active BCR-mediated responses. Aggregation
of the BCR has been shown to induce increased expression
of CD69 and CD86 on resting mature B cells (45), the latter
preparing them to present antigen to T cells. However, the
impact of specific signaling pathways on BCR-mediated in-
duction of activation marker expression is not well defined.
As BCR-mediated signals are amplified in SHIP-deficient B
cells, it seemed plausible that BCR-mediated induction of
activation marker expression could be similarly amplified.
As shown in Fig. 5, A and B, ex vivo SHIP2/2 B cells
expressed slightly elevated levels of CD86 and CD69 and
were more sensitive to BCR-mediated induction of these
markers than were their wild-type counterparts. In addi-
tion, because both molecules were induced at significantly
lower Ig concentrations in SHIP2/2 cells, SHIP increased
signaling thresholds for activation marker expression. These
results suggest that both BCR-linked signaling pathways
and modulation of gene expression are specifically regu-
lated by SHIP.
Splenic B Cells from SHIP2/2 Mice Are Less Susceptible to
BCR-mediated Cell Death. Under certain circumstances,
aggregation of the BCR leads to activation-induced cell
death via induction of apoptotic signaling pathways (46).
As PI(3,4,5)P3 has been shown to be a survival signal in
Figure 4. Increased rate of development of immature (IgM1) cells in
the bone marrow. 7-wk-old SHIP2/2 mice and wild-type littermates
were treated with sublethal irradiation (500 rads) to follow the kinetics of
regeneration of bone marrow B cells. Bone marrow was harvested from
two femurs at the indicated time points (8 and 9 d) after irradiation. Cells
were counted and stained for B220, IgM, mAb 493, and 7AAD (via
probe). Data show flow cytometric analysis of viable/B2201 cells from
the bone marrow of SHIP1/1 and SHIP2/2 mice 8 d (top) and 9 d (bot-
tom) after sublethal irradiation. 250,000 total cells were counted in each
case. 8 d after irradiation, the number of B2201 cells in the bone marrow
of SHIP1/1 mice was 5.0 3 105, while SHIP2/2 bone marrow had 4.7 3
105 B2201 cells. 9 d after irradiation, the number of B2201 cells in the
bone marrow of SHIP1/1 mice was 22 3 105, while SHIP2/2 bone mar-
row had 26 3 105 B2201 cells. Data shown are representative of three
replicate experiments
Figure 5. SHIP2/2 B cells display increased sensitivity to
BCR-mediated induction of activation marker expression.
SHIP2/2 or wild-type B cells were stimulated with the in-
dicated concentration of F(ab9)2 fragments of anti-IgG. (A)
After stimulation for 20 h, cells were analyzed. The mean
fluorescence intensity of CD86 expression was measured
on live/B2201 cells. (B) After a 6-h stimulation, the mean
fluorescence intensity of CD69 expression was measured.
Data shown represent the mean of triplicate determinants.1551 Brauweiler et al.
many cell models, SHIP-mediated degradation of PI(3,4,5)P3
could thus promote cell death in response to BCR ligation.
To test this possibility, resting splenic B cells were cultured
with increasing concentrations of F(ab9)2 anti-Ig, and the
percentage of surviving cells was determined 24 h later by
propidium iodide exclusion. As shown in Fig. 6, the
SHIP2/2 cells were more resistant to BCR-mediated cell
death than their SHIP1/1 counterparts, especially at ele-
vated concentrations of stimulus. Therefore, SHIP en-
hances the BCR-mediated apoptotic response of B cells,
presumably through elimination of PI(3,4,5)P3.
Discussion
Results reported here demonstrate an important role for
SHIP in regulation of signal transduction through the
BCR. Ligation of the BCR alone in SHIP2/2 B cells re-
sulted in dramatic and sustained elevations in PI(3,4,5)P3
compared with SHIP1/1 B cells. These results demonstrate
that, at least in part, SHIP regulatory function is mediated
through its enzymatic activity. Despite the overproduction
of PI(3,4,5)P3, SHIP-deficient B cells displayed no detect-
able increase in IP3 production, and only very modest in-
creases in calcium mobilization upon aggregation of the
BCR. Thus, the large increases in PI(3,4,5)P3 do not trans-
late into proportionally large increases in activation of
PLCg. These findings indicate that a distinct signaling
component must be limiting for BCR-mediated PLCg ac-
tivation. This conclusion is consistent with reports that lev-
els of Btk, an effector necessary for PLCg activation, has
been shown to limit BCR-mediated calcium mobilization
in the A20 B cell line (19, 32). However, these observa-
tions are discordant with studies showing that SHIP abla-
tion in the DT40 chicken lymphoma line significantly en-
hances BCR-mediated calcium mobilization responses
(35). It is possible that in the DT40 system, Btk is expressed
at higher levels, making PI(3,4,5)P3 the limiting element in
the PLC activation cascade.
Mutations in components of the BCR signaling complex
can severely influence B cell population dynamics and
function. SHIP ablation is clearly associated with an altered
biological phenotype. Characterization of the B cells from
SHIP-deficient mice revealed a 50% reduction in the num-
bers of pre- and immature B cells in the bone marrow, and
yet increased numbers of B cells in the spleen (34, 37). We
found that immature and transitional B cells are signifi-
cantly reduced in the splenic B cell compartment. Two
possible mechanisms could account for this phenotype, and
be a consequence of the amplified BCR signaling seen in
SHIP2/2 B cells: (a) an unusually large proportion of imma-
ture B cells may be deleted, with survivors expanding to fill
available space in the periphery; and (b) the rate of B cell
development may be accelerated, depleting the pre-, im-
mature, and transitional B cell pools. While the former
possibility was not formally excluded, we found that SHIP-
deficient bone marrow cells were fully competent to re-
constitute the mature splenic B cell compartment. SHIP2/2
and SHIP1/1 littermates differed primarily with respect to
the rapidity with which they traversed the immature and
transitional stages. In our studies of autoreconstitution, we
found that in SHIP2/2 mice B cells more rapidly repopu-
lated the splenic compartment. Although these studies sup-
port a hypothesis in which deletion of SHIP results in ac-
celerated maturation, the increased production of B cells
could additionally be a result of enhanced survival of transi-
tional B cells as they traverse into the mature B cell pool.
Development from the transitional to the mature B cell
stage is an active process that is reportedly dependent on
the strength of the constitutive BCR-mediated signal. For
example, loss of constitutive signal in CD45-deficient mice
(42, 47) results in a block at the late transitional stage, and
loss of mature cells in the periphery. Conversely, loss of
CD22 (48, 49), a negative regulator of B cell signaling, re-
sults in increased numbers of mature splenic B cells. SHIP
deficiency appears to amplify the constitutive BCR signal,
resulting in a rapid conversion from the transitional to the
mature stage, based on downmodulation of sIgM and HSA.
Therefore, modifications of the BCR complex that en-
hance constitutive signaling function also appear to en-
hance B cell development.
SHIP-deficient B cells also emigrated from the bone mar-
row at an accelerated rate, thus partially accounting for the
reduction in numbers of immature cells in SHIP-deficient
bone marrow. It is possible that B cell development and sur-
vival could be promoted through increased accumulation of
PI(3,4,5)P3 in SHIP-deficient B cells. Although other sig-
naling pathways may be necessary for signaling of develop-
ment, levels of PI(3,4,5)P3 appear to limit progression.
Previous reports have proposed that elevations in ty-
rosine phosphorylation, as a consequence of loss of tyrosine
phosphatases, can also change the signaling thresholds that
effect development and selection (50). Combined, these
studies suggest that levels of PI3-K activity and tyrosine ki-
Figure 6. SHIP2/2 splenic B cells are resistant to BCR-mediated in-
duction of cell death. Freshly isolated splenic B cells from SHIP2/2 mice
or control littermates were incubated at 2.0 3 106 cells/ml for 24 h with
the indicated concentrations of F(ab9)2 fragments of anti-IgG. The per-
centage of surviving cells was determined 24 h later based on recovery of
viable (propidium iodide excluding) cells. Data shown represent the mean
of triplicate determinants.1552 SHIP Inhibits B Cell Signaling, Maturation, and Activation
nase activity are central in regulation of signaling and de-
velopment mediated through the BCR. However, tyrosine
kinase activity is linked to PI3-K activity (51). For exam-
ple, efficient PI(3,4,5)P3 generation, during BCR signaling,
requires tyrosine phosphorylation of CD19, which subse-
quently recruits and activates PI3-K. Consistent with find-
ings reported here, B cells derived from CD19-deficient
mice are both deficient in PI3-K activation (15) and un-
usually immature, expressing the elevated levels of sIgM
characteristic of the transitional phenotype (52). Con-
versely, overexpression of CD19 renders B cells hyperre-
sponsive to transmembrane signals. CD19 transgenic mice
have increased levels of autoantibodies, and the B cell pop-
ulation is shifted toward the mature sIgMloIgDhi phenotype
(53). Deficiency in the regulatory subunit of PI3-K, p85a,
also leads to impaired B cell development. Thus, evidence
from several models supports a central role for PI(3,4,5)P3
in driving development.
Although the signaling events that trigger various stages
of development are not well defined, at least three signaling
molecules downstream of SHIP and PI3-K have recently
been implicated as potential regulators of B cell develop-
ment. Dominant active ras, as well as raf and MAP kinases
(42, 54, 55), can provide signals required for developmental
maturation in B cells. Intriguingly, the activation of ras/raf
and MAP kinase–mediated signaling events has been linked
positively to PI(3,4,5)P3 and negatively to SHIP. For
example, the PI3-K inhibitor, wortmannin, inhibits ras/raf-
mediated downstream activation of the MAP kinase path-
way (56), as does SHIP expression (34). Conversely, gener-
ation of PI(3,4,5)P3 can activate downstream signaling
pathways, including the induction of gene expression
through NF-kB (24). Interestingly, NF-kB is essential for
B cell development, as mice deficient in both NF-kB p50
and p52 (57) demonstrate a loss of peripheral B cells. Thus,
there are multiple parallel downstream pathways linked to
PI(3,4,5)P3 that are likely candidates for inhibition by SHIP
during B cell development. It is important to note that, in
addition to its enzymatic activity, SHIP may also function
as a linker protein. In some systems, SHIP has been shown
to bind with Shc and/or p62 dok (57a), both of which are
implicated in ras activation (58).
We also observe that some active BCR-mediated re-
sponses are negatively regulated through SHIP, as SHIP-
deficient B cells exhibit increased sensitivity to F(ab9)2
anti-Ig stimulation of CD86 and CD69 expression. As up-
regulation of CD86 is required for efficient T cell–B cell
collaboration, this provides an additional mechanism through
which SHIP could negatively regulate immune responses
and prevent aberrant stimulation. Although previous studies
using pharmacological agents indicate that CD86 and CD69
expression can be induced by calcium-activated pathways
(45), physiologic activation of these responses appears to be
limited by SHIP. SHIP may further mediate its inhibitory
effects through a block in ras signaling, as previous studies in
T cells have demonstrated inhibition of CD69 induction
upon overexpression of dominant negative ras (59).
Finally, we show the positive role of SHIP in regulation
of BCR-mediated cell death. Previous studies have shown
that in vitro ligation of the BCR results in apoptotic death
of B cells (46). Although SHIP negatively influences CD86
and CD69 expression, it is a positive mediator of the apop-
totic response (60), suggesting that degradation of PI(3,4,5)P3
promotes cell death. The mechanism of PI(3,4,5)P3-medi-
ated protection is unknown; however, Akt is activated
through PI(3,4,5)P3 and provides an antiapoptotic signal in
some tissues. Akt is believed to promote cell survival by
phosphorylation of Bad (61) and caspase-9 (62), and pro-
mote cell cycle progression (63). Thus, SHIP may contrib-
ute to the apoptotic signal through its degradation of
PI(3,4,5)P3 and resulting failed activation of Akt (21, 22).
Previous studies have demonstrated a critical role for
SHIP in mediating inhibitory signaling through FcgRIIB1
in B cells and mast cells (64). In this report, we demonstrate
an active role for SHIP as a critical regulator of B cell de-
velopment and antigen receptor–mediated activation. Our
results indicate that B cell development in both the bone
marrow and spleen is regulated by SHIP. We hypothesize
that SHIP deficiency enhances both tonic- and antigen-
mediated BCR signals driving B cell development, matura-
tion, and activation.
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